Koo Bon Seok, Choi Eun Chang, Yoon Yeo-Hoon, Kim Dong-Hyun, Kim Eung-Hyub, Lim Young Chang
Department of Otolaryngology-Head and Neck Surgery, Cancer Research Institute, Chungnam National University College of Medicine, Daejeon, Korea.
Ann Surg. 2009 May;249(5):840-4. doi: 10.1097/SLA.0b013e3181a40919.
To investigate the incidence and the risk factors for occult ipsilateral or contralateral central neck lymph node (LN)metastasis in patients with unilateral papillary thyroid carcinoma (PTC) and a clinically negative neck.
Elective central lymph node dissection (CLND) in patients with PTC remains controversial. There have been few prospective studies assessing accurate histopathologic information and predictive factors for the presence of metastasis to the ipsilateral or contralateral central compartment of the neck in patients with PTC and clinically negative neck nodes.
We reviewed a prospective protocol of 111 unilateral PTC patients with clinically node-negative necks who have received total thyroidectomy and elective bilateral CLND from 2005 to 2007. The relationships between LN metastasis to the ipsilateral or contralateral central neck compartment and clinico-pathologic factors such as age, sex, size of primary tumor, perithyroidal invasion, lymphovascular invasion, and capsular invasion were analyzed.
Occult central neck LN metastasis was present in 54.1% (60/111). Of these patients, bilateral central LN metastases were present in 50% (30/60), unilateral ipsilateral central LN metastasis in 43.3% (26/60), and unilateral contralateral central LN metastasis in 6.7% (4/60). In the univariate analysis, the rate of ipsilateral central LN metastasis was significantly higher in male patients, high risk MACIS score, carcinoma with a maximal diameter of greater than 1 cm, and carcinoma with lymphovascular invasion (P < 0.05). The rate of contralateral central LN metastasis was significantly higher in cases of carcinoma with a maximal diameter of greater than 1 cm, lymphovascular invasion or histologically proven metastasis to the ipsilateral central LN (P < 0.05). Multivariate analysis showed that the tumor size was an independent risk factor for the presence of ipsilateral central LN metastasis, and the presence of ipsilateral central LN metastasis was the only independent predictor for the presence of contralateral central LN metastasis.
Unilateral PTC with a maximal diameter of greater than 1 cm is associated with a high rate of ipsilateral central neck LN metastasis. Moreover, ipsilateral central LN metastasis is a potential independent predictor of synchronous contralateral central LN metastasis. These findings suggest that contralateral as well as ipsilateral elective CLND, performed during the initial thyroid operation, may be effective in the management of patients with unilateral PTC having a maximal diameter of greater than 1 cm and ipsilateral central LN metastasis.
探讨单侧甲状腺乳头状癌(PTC)且颈部临床检查阴性患者同侧或对侧中央区颈部淋巴结(LN)隐匿性转移的发生率及危险因素。
PTC患者的选择性中央区淋巴结清扫术(CLND)仍存在争议。很少有前瞻性研究评估PTC且颈部临床淋巴结阴性患者同侧或对侧颈部中央区转移的准确组织病理学信息及预测因素。
我们回顾了2005年至2007年期间111例单侧PTC且颈部临床淋巴结阴性患者的前瞻性方案,这些患者均接受了甲状腺全切术及选择性双侧CLND。分析了同侧或对侧中央区颈部淋巴结转移与年龄、性别、原发肿瘤大小(最大直径)、甲状腺周围侵犯、脉管侵犯及包膜侵犯等临床病理因素之间的关系。
隐匿性中央区颈部淋巴结转移发生率为54.1%(60/111)。其中,双侧中央区淋巴结转移占50%(30/60),单侧同侧中央区淋巴结转移占43.3%(26/60),单侧对侧中央区淋巴结转移占6.7%(4/60)。单因素分析显示,男性患者同侧中央区淋巴结转移率显著更高,MACIS高危评分、最大直径大于1 cm的癌以及有脉管侵犯的癌(P<0.05)。最大直径大于1 cm、有脉管侵犯或组织学证实同侧中央区淋巴结转移的病例中,对侧中央区淋巴结转移率显著更高(P<0.05)。多因素分析显示,肿瘤大小是同侧中央区淋巴结转移的独立危险因素,同侧中央区淋巴结转移是对侧中央区淋巴结转移的唯一独立预测因素。
最大直径大于1 cm的单侧PTC与同侧中央区颈部淋巴结高转移率相关。此外,同侧中央区淋巴结转移是对侧中央区淋巴结同步转移的潜在独立预测因素。这些发现表明,在初次甲状腺手术期间进行同侧及对侧选择性CLND,可能对最大直径大于1 cm且有同侧中央区淋巴结转移的单侧PTC患者的治疗有效。